South Africa to get 1.5 million COVID-19 vaccines from India
The vaccine, developed with the University of Oxford, is made from a virus which is a weakened version of a common cold virus (adenovirus), that has been genetically changed so that it is impossible for it to grow in humans.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Adenoviruses | African Health | Biotechnology | Common Cold | COVID-19 | Genetics | India Health | Oxford University | Pharmaceuticals | South Africa Health | Vaccines